Clinical Observation of Xiaochaihu Decoction Combined with Xiaoxianxiong Decoction in the Treatment of Post-stroke Pneumonia
Abstract
Objective: To investigate the clinical efficacy of Xiaochaihu Decoction combined with Xiaoxianxiong Decoction in the treatment of post-stroke pneumonia. Methods: To complete the sample grouping comparison, all patients with post-stroke pneumonia were investigated, and the number of cases was 60. These patients’ diseases were consistent with the dialectical standards of traditional Chinese medicine (phlegm-heat obstructing lungs). The patients were randomly divided into a control group (30 cases, treated with antibiotics and symptomatic methods) and a treatment group (30 cases, treated with Xiaochaihu Decoction and Xiaoxianxiong Decoction on the basis of the control group). Various indicators were compared. Results: The total clinical effective rates were 93% and 80% in the treatment group and the control group, respectively, with statistical significance (P < 0.05). The improvement of various clinical symptoms was compared, and the values in the treatment group were reduced, showing significance (P < 0.05). Analysis of serum factor indicators showed that the overall trend of the treatment group was reduced, and the comparison between groups was below 0.05. Conclusion: Xiaochaihu Decoction combined with Xiaoxianxiong Decoction has a significant clinical effect in the treatment of post-stroke pneumonia (phlegm-heat obstructing lungs syndrome), which can reduce inflammatory reactions and has few adverse reactions, worthy of clinical application
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.